Analysts Set Beam Therapeutics Inc. (NASDAQ:BEAM) Target Price at $51.00
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has been given an average recommendation of “Buy” by the fourteen research firms that are covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating, ten have issued a buy rating and two have assigned a strong buy rating to […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has been given an average recommendation of “Buy” by the fourteen research firms that are covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating, ten have issued a buy rating and two have assigned a strong buy rating to […]
